Cleavage of nucleic acid acid using thermostable methoanococcus jannaschii FEN-1 endonucleases

• US 5,843,669 A
• Filed: 11/29/1996
• Issued: 12/01/1998
• Est. Priority Date: 01/24/1996
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Lyamichev, Natasha, Lyamichev, Victor I., Kaiser, Michael W.
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): FREDMAN, JEFFREY NORMAN
• Application Number:
  US08/757,653
• Time in Patent Office: 732 Days
• Field of Search: 435/4, 435/6, 435/18, 435/91.53, 435/183, 435/194, 435/195, 435/196, 435/810, 435/822, 436/94, 530/350
• US Class Current: 435/6.18
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides
• CPC Class Codes: C12Q 2561/109 Invader technology
• CPC Class Codes: C12Q 2565/525 characterised by the capture oligonucleotide being double stranded
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/822 using bacteria or actinomycetales

Abstract

The present invention relates to means for cleaving a nucleic acid cleavage structure in a site-specific manner. Structure-specific nucleases, including 5'"'"' nucleases, thermostable FEN-1 endonucleases and 3'"'"' exonucleases, are used to detect and identify target nucleic acids. Methods are provided which allow for the detection specific nucleic acid sequences; these methods permit the detection and identification of mutant and wild-type forms of genes (e.g., human genes) as well as permit the detection and identification of bacterial and viral pathogens in a sample.

Claims

1. A mixture comprising a first structure-specific nuclease, said first nuclease consisting of the Mja FEN-1 endonuclease and a second structure-specific nuclease, wherein said second nuclease is a 5'"'"' nuclease derived from a thermostable DNA polymerase altered in amino acid sequence such that it exhibits reduced DNA synthetic activity from that of the wild-type DNA polymerase but retains substantially the same 5'"'"' nuclease activity of the wild-type DNA polymerase.

2. A mixture comprising a first structure-specific nuclease, said first nuclease consisting of the Mja FEN-1 endonuclease and a second structure-specific nuclease, wherein said second nuclease is selected from the group consisting of the Cleavase®

BN enzyme, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and the Saccharomyces cerevisiae Rad1/Rad10 complex.

3. A method for treating nucleic acid, comprising:

a) providing;

i) the Mja FEN-1 endonuclease; and

ii) a nucleic acid substrate;

b) treating said nucleic acid substrate under conditions such that said substrate forms one or more cleavage structures; and

c) reacting said endonuclease with said cleavage structures so that one or more cleavage products are produced.

4. The method of claim 3, further comprising providing a structure-specific nuclease derived from a thermostable DNA polymerase altered in amino acid sequence such that it exhibits reduced DNA synthetic activity from that of the wild-type DNA polymerase but retains substantially the same 5'"'"' nuclease activity of the wild-type DNA polymerase.

5. The method of claim 4, wherein a portion of the amino acid sequence of said second nuclease is homologous to a portion of the amino acid sequence of a thermostable DNA polymerase derived from a eubacterial thermophile of the genus Thermus.

6. The method of claim 5, wherein said thermophile is selected from the group consisting of Thermus aquaticus, Thermus flavus and Thermus thermophilus.

7. The method of claim 6, wherein said structure-specific nuclease is the Cleavase®

BN nuclease.

8. The method of claim 3, wherein said nucleic acid of step (a) is substantially single-stranded.

9. The method of claim 3, wherein said nucleic acid is RNA.

10. The method of claim 3, wherein said nucleic acid is DNA.

11. The method of claim 3, wherein said nucleic acid of step (a) is double stranded.

12. The method of claim 11, wherein said treating of step (b) comprises:

i) rendering said double-stranded nucleic acid substantially single-stranded; and

ii) exposing said single-stranded nucleic acid to conditions such that said single-stranded nucleic acid has secondary structure.

13. The method of claim 12, wherein said double stranded nucleic acid is rendered substantially single-stranded by the use of increased temperature.

14. The method of claim 3, further comprising the step of detecting said one or more cleavage products.

15. A method for treating nucleic acid, comprising:

a) providing;

i) a first structure-specific nuclease consisting of the Mja FEN-1 endonuclease in a solution containing manganese; and

ii) a nucleic acid substrate;

b) treating said nucleic acid substrate with increased temperature such that said substrate is substantially single-stranded;

c) reducing said temperature under conditions such that said single-stranded substrate forms one or more cleavage structures;

d) reacting said cleavage means with said cleavage structures so that one or more cleavage products are produced; and

e) detecting said one or more cleavage products.

16. The method of claim 15, comprising providing a second structure-specific nuclease.

17. The method of claim 16, wherein said second nuclease is selected from the group consisting of the Cleavase®

BN enzyme, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and the Saccharomyces cerevisiae Rad1/Rad10 complex.

18. The method of claim 15, wherein said nucleic acid is RNA.

19. The method of claim 15, wherein said nucleic acid is DNA.

20. The method of claim 15, wherein said nucleic acid of step (a) is double stranded.

21. A nucleic acid treatment kit, comprising:

a) a composition comprising the Mja FEN-1 endonuclease; and

b) a solution containing manganese.

22. The kit of claim 21, further comprising a second structure-specific nuclease.

23. The kit of claim 22, wherein said second nuclease is a 5'"'"' nuclease derived from a thermostable DNA polymerase altered in amino acid sequence such that it exhibits reduced DNA synthetic activity from that of the wild-type DNA polymerase but retains substantially the same 5'"'"' nuclease activity of the wild-type DNA polymerase.

24. The kit of claim 23, wherein a portion of the amino acid sequence of said second nuclease is homologous to a portion of the amino acid sequence of a thermostable DNA polymerase derived from a eubacterial thermophile of the genus Thermus.

25. The kit of claim 24, wherein said thermophile is selected from the group consisting of Thermus aquaticus, Thermus flavus and Thermus thermophilus.

26. The kit of claim 21, further comprising reagents for detecting said cleavage products.